Analysts Issue Forecasts for Centene FY2026 Earnings

Centene Co. (NYSE:CNCFree Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Centene in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst S. James expects that the company will post earnings per share of $8.26 for the year. The consensus estimate for Centene’s current full-year earnings is $6.86 per share.

Centene (NYSE:CNCGet Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $2.90 EPS for the quarter, beating analysts’ consensus estimates of $2.52 by $0.38. The firm had revenue of $46.62 billion during the quarter, compared to the consensus estimate of $43.16 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. The firm’s revenue for the quarter was up 15.4% compared to the same quarter last year. During the same quarter last year, the firm earned $2.26 EPS.

CNC has been the subject of several other research reports. Barclays reissued an “equal weight” rating and issued a $65.00 price objective (down previously from $84.00) on shares of Centene in a research note on Monday, June 2nd. Morgan Stanley assumed coverage on shares of Centene in a research note on Monday. They set an “overweight” rating and a $70.00 price target for the company. Wells Fargo & Company decreased their price target on shares of Centene from $76.00 to $72.00 and set an “overweight” rating for the company in a research note on Friday, February 14th. Guggenheim reaffirmed a “neutral” rating on shares of Centene in a research note on Tuesday, April 29th. Finally, Jefferies Financial Group decreased their price target on shares of Centene from $64.00 to $61.00 and set a “hold” rating for the company in a research note on Tuesday, April 29th. Seven research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $77.71.

Check Out Our Latest Stock Report on Centene

Centene Stock Down 0.5%

Shares of NYSE CNC opened at $55.49 on Tuesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The company has a market cap of $27.61 billion, a P/E ratio of 8.89, a PEG ratio of 0.80 and a beta of 0.45. Centene has a 1 year low of $54.01 and a 1 year high of $80.59. The firm has a 50-day simple moving average of $59.69 and a two-hundred day simple moving average of $60.03.

Hedge Funds Weigh In On Centene

Institutional investors have recently bought and sold shares of the business. Ameriflex Group Inc. purchased a new position in Centene during the fourth quarter valued at approximately $26,000. Pinney & Scofield Inc. purchased a new position in Centene in the fourth quarter worth $25,000. Capital Advisors Ltd. LLC grew its holdings in Centene by 75.3% in the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after purchasing an additional 177 shares during the last quarter. Hurley Capital LLC purchased a new position in Centene in the fourth quarter worth $26,000. Finally, Quarry LP purchased a new position in Centene in the first quarter worth $26,000. 93.63% of the stock is owned by hedge funds and other institutional investors.

Centene Company Profile

(Get Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

See Also

Earnings History and Estimates for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.